Moderna Secures FDA Approval for First mRNA Influenza Vaccine

By Helen Branswell · STAT News · 2026-08-06

Moderna Secures FDA Approval for First mRNA Influenza Vaccine

STAT News reports that the FDA has authorized mFlusiva, marking the first time messenger RNA technology will be used in a seasonal flu shot for adults. The decision concludes a turbulent regulatory path involving a previously overturned rejection by the agency's biologics departm

STAT News reports that the FDA has authorized mFlusiva, marking the first time messenger RNA technology will be used in a seasonal flu shot for adults. The decision concludes a turbulent regulatory path involving a previously overturned rejection by the agency's biologics departm